Also from this source


You just read:

Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease

News provided by

Takeda Pharmaceutical Company Limited

05 Jul, 2016, 02:00 ET